Showing 201 - 220 results of 3,518 for search '"Tumor suppressor gene"', query time: 0.71s Refine Results
  1. 201

    Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. by Ramin Radpour, Zeinab Barekati, Corina Kohler, Qing Lv, Nicole Bürki, Claude Diesch, Johannes Bitzer, Hong Zheng, Seraina Schmid, Xiao Yan Zhong

    Published 2011-01-01
    “…In the first cohort, circulating cell free methylated DNA of the 8 tumor suppressor genes (TSGs) was significantly higher in patients with breast cancer compared to normal controls (P<0.01). …”
    Get full text
    Article
  2. 202
  3. 203

    The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. by Banham, A, Beasley, N, Campo, E, Fernandez, P, Fidler, C, Gatter, K, Jones, M, Mason, D, Prime, J, Trougouboff, P, Wood, K, Cordell, J

    Published 2001
    “…Our study identifies FOXP1 as a new candidate tumor suppressor gene localized to the chromosome 3p14.1 region.…”
    Journal article
  4. 204
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213

    The tumor suppressor gene <it>KCTD11</it><sup><it>REN </it></sup>is regulated by Sp1 and methylation and its expression is reduced in tumors by Rinaldi Christian, Di Camillo Raffaello, Murgo Simona, Po Agnese, Capece Daria, Ciccocioppo Lucia, Zazzeroni Francesca, Mancarelli M Michela, Ferretti Elisabetta, Gulino Alberto, Alesse Edoardo

    Published 2010-06-01
    “…Although loss of 17p13 has been often associated with <it>p53 </it>genetic alteration or Hypermethylated in Cancer 1 (<it>HIC1</it>) gene hypermethylation, other tumor suppressor genes (TSGs) located in this region have critical roles in tumorigenesis. …”
    Get full text
    Article
  14. 214

    A Novel Mutation in the Von Hippel-Lindau Tumor Suppressor Gene Identified in a Patient Presenting with Gestational Diabetes Mellitus by Yun Hyi Ku, Chang Ho Ahn, Chan-Hyeon Jung, Jie Eun Lee, Lee-Kyung Kim, Soo Heon Kwak, Hye Seung Jung, Kyong Soo Park, Young Min Cho

    Published 2013-12-01
    “…We present a novel mutation in the VHL tumor suppressor gene that presented with gestational diabetes mellitus.MethodsA 30-year-old woman presented with gestational diabetes mellitus. …”
    Get full text
    Article
  15. 215
  16. 216

    A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability. by Mahdieh Jadaliha, Omid Gholamalamdari, Wei Tang, Yang Zhang, Ana Petracovici, Qinyu Hao, Aamira Tariq, Tae Gyoon Kim, Sarah E Holton, Deepak K Singh, Xiao Ling Li, Susan M Freier, Stefan Ambs, Rohit Bhargava, Ashish Lal, Supriya G Prasanth, Jian Ma, Kannanganattu V Prasanth

    Published 2018-11-01
    “…Our studies demonstrate crucial roles played by NAT lncRNAs in regulating post-transcriptional gene expression of key oncogenic or tumor suppressor genes, thereby contributing to TNBC progression.…”
    Get full text
    Article
  17. 217
  18. 218

    Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers by Yiting Chen, Yiting Chen, Jieling Ning, Wenjie Cao, Shuanglian Wang, Tao Du, Jiahui Jiang, Xueping Feng, Bin Zhang

    Published 2020-10-01
    “…In addition, we also summarize emerging insights on TXNIP expression and its functional role in different kinds of cancers, as well as clarify its participation in metabolic reprogramming and oxidative stress in cancer cells, wherein it acts as a putative tumor suppressor gene to inhibit the proliferation, invasion, and migration of different tumor cells as well as promote apoptosis in these cells. …”
    Get full text
    Article
  19. 219
  20. 220

    The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis by Jenni Lahtela, Barun Pradhan, Katja Närhi, Annabrita Hemmes, Merja Särkioja, Panu E. Kovanen, Arthur Brown, Emmy W. Verschuren

    Published 2015-04-01
    “…Therapeutic responses are further defined by the landscape of passenger mutations, or loss of tumor suppressor genes. We report here a thorough study to address the physiological role of the putative lung cancer tumor suppressor EPH receptor A3 (EPHA3), a gene that is frequently mutated in human lung adenocarcinomas. …”
    Get full text
    Article